CCL18 and breast carcinoma: Our previous data revealed that CCL18 promotes extracellular matrix adherence and breast cancer cell invasion by binding to its potential cognate surface receptor PITPNM3, whose expression is essential for CCL18-induced calcium influx and chemotaxis [15].